<?xml version="1.0" encoding="UTF-8"?>
<ref id="B87" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Van der Stoep</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Quinten</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Marcondes Rezende</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Van den Elsen</surname>
    <given-names class="given-names">P. J.</given-names>
   </name>
  </person-group> (
  <year class="year">2004</year>). 
  <article-title class="article-title">E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII)</article-title>. 
  <source class="source">Blood</source>
  <volume class="volume">104</volume>, 
  <fpage class="fpage">2849</fpage>â€“
  <lpage class="lpage">2857</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1182/blood-2004-03-0790</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">15242870</pub-id>
 </mixed-citation>
</ref>
